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Background: The growth-inhibiting and morphostructural effects of seven constituents identified in Asarum
heterotropoides root on 14 intestinal bacteria were compared with those of the fluoroquinolone antibiotic
ciprofloxacin.
Method: A microtiter plate-based bioassay in sterile 96-well plates was used to evaluate the minimal inhibitory
concentrations (MICs) of the test materials against the organisms.
Results: δ-3-Carene (5) exhibited the most potent growth inhibition of Gram-positive bacteria (Clostridium difficile
ATCC 9689, Clostridium paraputrificum ATCC 25780, Clostridium perfringens ATCC 13124, and Staphylococcus aureus
ATCC 12600) and Gram-negative bacteria (Escherichia coli ATCC 11775 and Bacteroides fragilis ATCC 25285) (minimal
inhibitory concentrations (MIC), 0.18–0.70 mg/mL) except for Salmonella enterica serovar Typhimurium ATCC 13311
(MIC, 2.94 mg/mL). The MIC of methyleugenol (2), 1,8-cineole (3), α-asarone (4), (−)-asarinin (6), and pellitorine
(7) was between 1.47 and 2.94 mg/mL against all test bacteria (except for compound 2 against C. difficile
(0.70 mg/mL); compounds 1 (23.50 mg/mL) and 4 (5.80 mg/mL) against C. paraputricum; compounds 2 (5.80 mg/mL),
4 (12.0 mg/mL), and 7 (0.70 mg/mL) against C. perfringens); compound 1 against E. coli (7.20 mg/mL) and S. enterica
serovar Typhimurium (12.0 mg/mL). Overall, all of the constituents were less potent at inhibiting microbial growth than
ciprofloxacin (MIC, 0.063–0.25 mg/ mL). The lactic acid-producing bacteria (four bifidobacteria and two lactobacilli) and
one acidulating bacterium Clostridium butyricum ATCC 25779 were less sensitive and more susceptible than the five
harmful bacteria and two nonpathogenic bacteria (B. fragilis and E. coli) to the constituents and to ciprofloxacin,
respectively. Beneficial Gram-positive bacteria and harmful and nonpathogenic Gram-negative bacteria were observed
to have different degrees of antimicrobial susceptibility to the constituents, although the antimicrobial susceptibility of
the harmful Gram-positive bacteria and the harmful and nonpathogenic Gram-negative bacteria was not observed.
Scanning electron microscopy observations showed different degrees of physical damage and morphological
alteration to both Gram-positive and Gram-negative bacteria treated with α-asarone, δ-3-carene, pellitorine, or
ciprofloxacin, indicating that they do not share a common mode of action.
Conclusion: A. heterotropoides root-derived materials described merit further study as potential antibacterial products
or lead molecules for the prevention or eradication from humans from diseases caused by harmful intestinal bacteria.
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In humans, various microorganisms reside in the gastro-
intestinal tract as a highly complex ecosystem with con-
siderable species diversity (approximately 500–1,000
bacterial species) [1]. Gastrointestinal ecological investi-
gations have indicated that the normal microbiota is pre-
dominantly composed of lactic acid-producing bacteria,
whereas the microbiota of cancer patients or elderly sub-
jects is mainly composed of Clostridium with only few
lactic acid-producing bacteria [2-4]. The microbiota par-
ticipate in normal physiological functions, including
metabolic activities that result in salvage of energy and
absorbable nutrients, and important trophic effects on
intestinal epithelia and on immune structure and func-
tion [5,6]. It also contribute to the genesis of various dis-
ease states by biotransforming a variety of ingested or
endogenously formed compounds to potentially harmful
metabolites such as N-nitroso compounds or aromatic
steroids [6-8]. Prolonged treatment with antibiotics al-
ters the normal microbial population of the gastrointes-
tinal tract, eliminating some of the beneficial bacteria [4]
and often producing resistance to the drugs by patho-
genic microorganisms [8,9], which is a major global pub-
lic health problem in both developed and developing
countries. Sometimes, serious side effects of antibiotics
occur, such as taste disturbances, nausea, diarrhea, dys-
pepsia, headache, and angioedema [10]. There is, there-
fore, a critical need for the development of new improved
antibacterial agents with novel target sites and low
toxicity.
Plant secondary substances may provide potential
sources of growth modulators against gastrointestinal
bacteria largely because higher plants constitute a poten-
tial source of bioactive chemicals that have been per-
ceived by the general public as relatively safe and with
minimal impacts to human health [11-13]. They can act
at multiple and novel target sites, thereby reducing the
potential for resistance [14]. Much effort has been fo-
cused on plant preparations as potential sources of com-
mercial growth promoters of beneficial intestinal
bacteria and/or growth inhibitors of harmful intestinal
bacteria. In the screening of plants for antibacterial ac-
tivity, a methanol extract of Asarum heterotropoides
(Aristolochiaceae) was shown to have growth inhibitory
activity against Bacteroides fragilis ATCC 25285 and
Clostridium perfringens ATCC 13124. Historically, A.
heterotropoides has long been used as an analgesic and
antitussive agent for the treatment of influenza, headache,
rheumatic pain, and asthma [15]. No information has been
obtained concerning the potential of A. heterotropoides
root-derived materials to modulate human gastrointestinal
bacteria, despite its excellent pharmacological action, such
as antiallergic, antihyperlipdemic, liver protective, antihis-
tamine, and antimicrobial activities [15].In the current study, an assessment is made of the
growth inhibitory activity of seven constituents identified
in A. heterotropoides root against five harmful intestinal
bacteria, two nonpathogenic intestinal bacteria, and seven
beneficial intestinal bacteria (six lactic acid-producing
bacteria and one acidulating bacterium), including
Gram-positive bacteria and Gram-negative bacteria,
using a microtiter plate-based bioassay. The growth in-
hibitory activity of the constituents was compared with
that of ciprofloxacin, a second-generation fluoroquino-
lone antibiotic with a broad spectrum [16]. The effects
of the constituents on morphological changes of the
bacterial strains were examined using scanning electron
microscopy (SEM). The possible mode of action of the
constituents is also discussed.
Methods
Instrumental analyses
1H and 13C NMR spectra were recorded in CDCl3 or
MeOD on a Bruker AVANCE 600 spectrometer (Karlsruhe,
Germany) using tetramethylsilane as an internal standard,
and chemical shifts are given in δ (ppm). UV spectra
were obtained in ethanol on a Kontron UVICON 933/
934 spectrophotometer (Milan, Italy), FT-IR spectra on
a Thermo Scientific Nicolet 6700 FT-IR (Madison, WI),
and mass spectra on a Jeol JMS-DX 303 spectrometer
(Tokyo, Japan). Optical rotation was measured with a
Rudolph Research Analytical Autopol III polarimeter
(Flanders, NJ, USA). Merck silica gel (0.063–0.2 mm)
(Darmstadt, Germany) was used for column chroma-
tography. Merck precoated silica gel plates (Kieselgel
60 F254) were used for analytical thin-layer chromatog-
raphy (TLC). Merck preparative silica gel plates and an
Agilent 1200 series high-performance liquid chroma-
tography (HPLC) (Santa Clara, CA, USA) were used for
isolation of active principles.
Plant sample
Air-dried root (600 g) of A. heterotropoides was purchased
from Boeun medicinal herb shop, Kyoungdong market
(Seoul, South Korea). It was identified by Dr. Sang-Cheol
Shin, Korea Forest Research Institute. A voucher speci-
men (AHR-01) was deposited in the Research Institute
for Agriculture and Life Science, Seoul National
University.
Bacterial strains and culture conditions
Five harmful intestinal bacteria, two nonpathogenic in-
testinal bacteria, six lactic acid-producing intestinal bac-
teria, and one acidulating bacterium examined in this
study are listed in Table 1. They were purchased from
the American Type Culture Collection (ATCC). Stock
cultures of these bacterial strains were routinely stored
on BHI broth (Becton, Dickinson and Company, Sparks,
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were subcultured on BHI broth (pH 7.6). The cultures
were incubated at 37°C for 1 day in an atmosphere of
5% H2, 15% CO2, and 80% N2 in a Hirayama anaerobic
chamber (Tokyo, Japan), except for the cultures of
Escherichia coli and Staphylococcus aureus which were in-
cubated at 37°C for 1 day under aerobic condition. For
bioassay, bacterial suspensions containing 1 × 105 colony-
forming unit (CFU)/mL were prepared in EG agar (Eiken
Chemical, Tokyo) using the 24 h subcultures in BHI
broth. The cell density was estimated by measuring the
turbidity.
Extraction and isolation
Extraction procedures of air-dried root of A. heterotropoides
were performed as reported previously [18]. The
hexane-soluble fraction (10 g) was most active and was
chromatographed on a 70 × 5.5 cm silica gel column
(600 g) and eluted with a gradient of hexane and ethyl
acetate [(10:1 (2.2 L), 9:1 (2 L), 7:3 (2 L), 5:5 (1 L), and
3:7 (1 L) by volume] and finally with methanol (1 L) to
provide 48 fractions (each about 250 mL). Column frac-
tions were monitored by TLC on silica gel plates with
hexane and ethyl acetate (7:3 by volume). Fractions
with similar Rf values on the TLC plates were pooled.Spots were detected by spraying with 2% H2SO4 and then
heating on a hot plate. Fractions 1–4 (2.92 g) were purified
by preparative TLC with hexane and ethyl acetate (7:3 by
volume) to yield two active principles 1 (465 mg, Rf =
0.73) and 2 (720 mg, Rf = 0.94). Fractions 5–8 (450 mg)
were purified by preparative TLC with hexane and ethyl
acetate (7:3 by volume) to provide three active principles 3
(15 mg, Rf = 0.58), 4 (75 mg, Rf = 0.61), and 5 (23 mg, Rf =
0.63). Fractions 15–27 (760 mg) were recrystallized in
methanol at −4°C to afford an active principle 6 (2.11 mg).
A preparative HPLC was used for separation of the con-
stituents from the active fractions 28–32 (739 mg). The
column was a 21.2 mm i.d. × 250 mm Phenomenex Prod-
igy ODS (Torrance, CA) using a mobile phase of aceto-
nitrile and water (8:2 by volume) at a flow rate of
1.5 mL/min. Chromatographic separations were moni-
tored using a UV detector at 254 nm. Finally, an active
principle 7 (12 mg) was isolated at a retention time of
10.89 min.
Growth-inhibiting assay
A microtiter plate-based bioassay in sterile 96-well plates
was used to evaluate the minimal inhibitory concentra-
tions (MICs) of the test materials against the organisms
[19]. In brief, initial test materials were prepared in
dimethylsulfoxide (DMSO), and 2-fold serial dilutions
were then performed in 50 μL EG broth. Subsequently,
10 μL bacterial suspension of each strain was added.
Ciprofloxacin (Sigma-Aldrich, St. Louis, MO, USA)
served as a positive control and were similarly prepared.
Negative controls consisted of the DMSO solution. The
plates were incubated at 37°C under anaerobic condi-
tions in a Hirayama chamber as stated previously, except
for the plates of S. aureus and E. coli which were incu-
bated at 37°C under aerobic conditions. After 24 h incu-
bation, 10 μL of resazurin solution (270 mg resazurin in
40 mL sterile distilled water) was added to each well.
Scanning electron microscopy
Both chemical-untreated (control) and -treated bacterial
samples were centrifuged at 3000 × g at 4°C for 5 min.
The bacterial pellets were primarily fixed in Karnovsky’s
fixative (2% glutaraldehyde (v/v) and 2% paraformalde-
hyde (v/v) in 0.05 M sodium cacodylate buffer pH 7.2)
[20]. The samples were incubated at 4°C in darkness for
2–4 h. They were then washed three times with the
same buffer. Second fixing was performed with 1% OsO4
(w/v) in the same buffer at 4°C for 2 h. Fixed samples
were washed two times with the same buffer and dis-
tilled water. The samples were then dehydrated in a
graded series of ethanol increasing concentrations up to
100% for 10 min. Finally, samples were substituted to
hexamethyldisilazane and dried in a Bio-Rad E3000 crit-
ical point drying machine (Cambridge, MA, USA).
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scanning electron microscope (Tokyo) at 20 kV.
Data analysis
MICs were defined as the lowest concentrations that visu-
ally inhibited bacterial growth using resazurin indicator.
All bioassays were repeated three times in triplicate and
standard error was 0–6% of the values. A constituents
having MIC >120 mg/mL was considered to be ineffective.
Bonferroni multiple-comparison method was used to test
for significant differences among the treatments (SAS
OnlineDoc, Version 8.01; SAS Institute, Cary, NC, USA).
Results
Bioassay-guided fractionation and identification
Fractions obtained from the solvent hydrolyzable of the
methanol extract of A. heterotropoides root were tested
against five harmful intestinal bacteria and two non-
pathogenic intestinal bacteria by a microtiter plate-based
bioassay (Table 2). Based on MIC values, the methanol
extract was proved to have growth inhibitory activity
against all of the intestinal bacteria. The hexane-soluble
fraction showed the most potent growth inhibition,
followed by the ethyl acetate- and chloroform-soluble
fractions. Weak and no growth inhibition were produced
by the butanol- and water-soluble fractions, respectively.
The beneficial intestinal bacteria were less susceptible
than the harmful intestinal bacteria to the root-derived
materials, although the hexane-soluble fraction showed
the most potent growth inhibition (Table 3). Therefore,
the hexane-soluble fraction was used to identify peak ac-
tivity fractions for the next step in the purification.
Microtiter plate-based assay-guided fractionation of A.
heterotropoides root extract afforded seven antibacterialTable 2 Minimal inhibitory concentrations (MICs) of fractions
extract of Asarum heterotropoides root against harmful and n
based antibacterial bioassay
Gram-positive bacteriab
Materiala Cd Cm Cp
ME 14.70 bA 7.35 cB 7.35 cB
HSF 7.35 cB 14.70 bA 7.35 cB
CSF 14.70 bA 14.70 bA 14.70 bA
EASF 7.35 cB 7.35 cB 14.70 bA
BSF 29.40 aB 58.80 aA 29.40 aB
WSF NAe NA NA
Means in a column followed by the same lowercase letter and means in a row follo
Bonferroni test).
aME, methanol extract; HSF, hexane-soluble fraction; CSF, chloroform-soluble faction
water-soluble fraction.
bCd, C. difficile ATCC 9689; Cm, C. paraputiricum ATCC 25780; Cp, C. perfringens ATC
cBf, B. fragilis ATCC 25285; Ec, E. coli ATCC 11775; St, S. enterica serovar Typhimurium
dNonpathogenic bacteria.
eNo activity.principles identified by spectroscopic analyses, including
MS and NMR. The seven antibacterial principles were
safrole (1), methyleugenol (2), 1,8-cineole (3), α-asarone
(4), δ-3-carene (5), (−)-asarinin (6), and pellitorine (7)
(Figure 1). Safrole (1) was identified on the basis of the
following evidence: pale yellow viscous oil. UV (EtOH):
λmax nm 210, 290. EI-MS (70 eV), m/z % relative inten-
sity): 162 [M]+ (40), 131 (46), 104 (71), 91 (17), 77 (100),
63 (8), 51 (25), 41 (6). 1H NMR (CDCl3, 600 MHz): δ
3.31 (2H, d, J = 6.66 Hz), 5.07 (1H, m), 5.10 (1H, d, J =
1.56 Hz), 5.92 (1H, m), 6.01 (1H, s), 6.61 (1H, d, J =
3.54 Hz), 6.70 (1H, s), 6.75 (2H, d, J = 7.86 Hz). 13C
NMR (CDCl3, 150 MHz): δ 39.8 t, 100.7 t, 108.1 d, 108.3
d, 115.3 t, 121.2 d, 133.8 s, 137.5 d, 145.8 s, 147.6 s.
Methyleugenol (2): viscous oil. UV (EtOH): λmax nm
254. EI-MS (70 eV), m/z (rel. int.): 178 [M]+ (100), 163
(26.3), 147 (21.4), 135 (5.6), 115 (4.8), 91 (10.9), 77 (5.8).
1H NMR (MeOD, 600 MHz) : δ 3.31 (2H, s), 3.78 (6H,
s), 4.83 (2H, s), 5.92 (1H, m), 6.70 (1H, d, J =1.56 Hz),
6.76 (1H, s), 6.85 (1H, d, J =8.16 Hz). 13C NMR (MeOD,
150 MHz): δ 39.8 t, 56.1 q, 56.1 q, 112.3 d, 114.1 d,
115.9 t, 122.3 d, 133.2 s, 136.5 d, 146.8 s, 149.7 s. 1,8-
Cineole (3): colorless oil. UV (EtOH): λmax nm 210. EI-
MS (70 eV), m/z (% relative intensity): 154 [M]+ (23),
139 (19), 126 (5), 111 (25), 108 (29), 93 (56), 71 (36), 69
(28), 43 (100). 1H NMR (CDCl3, 600 MHz): δ 1.09 (3H, s),
1.29 (6H, s), 1.43 (1H, s) 1.53 (4H, d, J = 8.58 Hz), 1.69
(2H, d, J = 11.28 Hz), 2.01 (2H, d, J = 2.16 Hz). 13C NMR
(CDCl3, 150 MHz): δ 23.8 t, 23.9 t, 25.5 q, 28.8 q, 28.8 q,
37.0 t, 37.1 t, 39.5 d, 71.3 s, 75.6 s. α-Asarone (4): viscous
oil. UV (EtOH): λmax nm 254. EI-MS (70 eV), m/z (relative
intensity): 208 [M]+ (100), 193 (51.8), 177 (10), 165 (7.5),
134 (3.3), 77 (4.9), 69 (1.6). 1H NMR (MeOD, 600 MHz):
δ 3.32 (3H, d, J = 5.4 Hz), 3.73 (3H, s), 3.75 (3H, s), 3.78obtained from the solvent hydrolyzable of the methanol
onpathogenic intestinal bacteria using a microtiter plate-
MIC (mg/mL)
Gram-negative bacteriac
Sa Bfd Ecd St
14.70 bA 7.35 bB 14.70 bA 7.35 bB
7.35 cB 3.67 cC 7.35 cB 3.67 cC
7.35 cB 7.35 bB 14.70 bA 7.35 bB
7.35 cB 1.83 dC 14.70 bA 7.35 bB
29.40 aB 58.80 aA 58.80 aA 14.70 aC
NA NA NA NA
wed by the same uppercase letter are not significantly different (P > 0.05;
; EASF, Ethyl acetate-soluble fraction; BSF, butanol-soluble fraction; WSF,
C 13124; Sa, S. aureus ATCC 12600.
ATCC 13311.
Table 3 Minimal inhibitory concentrations (MICs) of fractions obtained from the solvent hydrolyzable of the methanol
extract of Asarum heterotropoides root against beneficial Gram-positive intestinal bacteria using a microtiter plate-
based antibacterial bioassay
MIC (mg/mL)
Materiala Bbb Bib Beb Blb Lab Lcb Cbc
ME 60.67 aA 58.50 bB 58.50 aB 58.50 aB 29.30 bC 58.50 aB 58.50 aB
HSF 29.30 dB 29.30 cB 29.30 bB 29.30 bB 29.30 bB 58.50 aA 29.30 bB
CSF 55.87 cB 58.50 bA 58.50 aA 29.30 bC 29.30 bC 58.50 aA 58.50 aA
EASF 58.50 bB 117.0 aA 58.50 aB 58.50 aB 58.50 aB 55.87 bC 58.50 aB
BSF NAd NA NA NA NA NA NA
WSF NA NA NA NA NA NA NA
Means in a column followed by the same lowercase letter and means in a row followed by the same uppercase letter are not significantly different (P > 0.05;
Bonferroni test).
aME, methanol extract; HSF, hexane-soluble fraction; CSF, chloroform-soluble faction; EASF, Ethyl acetate-soluble fraction; BSF, butanol-soluble fraction; WSF,
water-soluble fraction.
bLactic acid-producing bacteria: Bb, B. bifidum ATCC 29521; Bi, B. infantis ATCC 25962; Be, B. breve ATCC 15700; Bl, B. longum ATCC 15707; La, L. acidophilius ATCC
4356; Lc, L. casei ATCC 393.
cAcidulating bacteria: Cb, C. butyricum ATCC 25779.
dNo activity.
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13C NMR (MeOD, 150 MHz): δ 34.79 q, 56.67 q, 56.96 q,
57.02 q, 99.74 d, 115.3 d, 116.1 s, 121.6 d, 137.8 d, 144.4 s,
149.9 s, 154.5 s. δ-3-Carene (5): colorless viscous oil. UV
(EtOH): λmax nm 210. EI-MS (70 eV), m/z (% relativeFigure 1 Active principles of Asarum heterotropoides root. Structures o
δ-3-carene (5), (−)-asarinin (6), and pellitorine (7).intensity): 136 [M]+ (18), 121 (22), 105 (12), 93 (100), 79
(32), 61 (13), 53 (17), 41 (36). 1H NMR (MeOD, 600 MHz):
δ 0.62 (2H, t, J = 8.58 Hz), 0.73 (3H, t, J = 8.22Hz), 1.03
(3H, s), 1.78 (3H d, J = 1.14 Hz), 2.16 (2H, dd, J = 11.0 and
6.84 Hz), 2.34 (2H, d, J = 3.72 Hz), 5.24 (1H, s). 13C NMRf safrole (1), methyleugenol (2), 1,8-cineole (3), α-asarone (4),
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23.6 q, 24.6 q, 28.3 t, 119.4 d, 131.3 s. (−)-Asarinin (6):
white powder or needle. [α] 15.6D : –153
o (c +002; chloro-
form). UV (EtOH): λmax nm 241. EI-MS (70 eV), m/z
(relative intensity): 354 [M]+ (33), 323 (11.3), 203 (14.5),
178 (13.1), 161 (25), 149 (100), 135 (43), 122 (20.4). IR
(CDCl3) vmax: 2963, 2897, 1500, 1488, 1439, 1371, 1253,
1032, 960, 794, 736. 1H NMR (CDCl3, 600 MHz): δ 2.84
(2H, dd, J = 4.2 and 13.2 Hz), 3.30 (2H, m), 3.84 (2H,
m), 4.11 (1H, d, J = 11.4 Hz), 4.41 (1H, d, J = 6.6 Hz), 5.95
(4H, d, J = 7.2 Hz), 6.79 (4H, m), 6.86 (1H, s), 6.88 (1H, s).
13C NMR (CDCl3, 150 MHz): δ 50.3 d, 54.8 d, 69.8 t,
71.1 t, 82.2 d, 87.8 d, 101.1 t, 101.3 t, 106.6 d, 106.8 d,
108.3 d, 108.4 d, 118.8 d, 119.7 d, 132.4 s, 135.3 s, 146.7 s,
147.4 s, 147.8 s, 148.1 s. Pellitorine (7): viscous oil. UV
(EtOH): λmax nm 220. EI-MS (70 eV), m/z (relative inten-
sity): 223 [M]+ (45.2), 208 (10), 180 (6.2), 167 (8.5), 152
(100), 113 (9.7), 96 (22.3), 72 (5.8). 1H NMR (CDCl3,
600 MHz): δ 0.88 (3H, s), 0.91 (3H, s), 0.93 (3H, s), 1.28
(4H, m), 1.37 (2H, d, J = 12.0 Hz), 1.75 (2H, m), 2.23 (1H, d,
J = 6.6 Hz), 3.17 (2H, t, J =6.4 and 12.9 Hz), 5.56 (1H, m),
5.76 (1H, m), 6.09 (1H, m), 7.19 (1H, m), 8.03 (1H, s). 13C
NMR (CDCl3, 150 MHz): δ 13.3 q, 20.1 q, 20.1 q, 22.5 t,
28.5 t, 28.6 d, 31.4 t, 32.9 t, 47.1 t, 121.7 d, 128.2 d,
141.3 d; 142.2 d, 166.4 s. The interpretations of proton
and carbon signals of compounds 1, 3, 5, and 2, 4, 6, and
7 were largely consistent with those of del Fierro et al.
[21], Liu et al. [22], Johnson and Kadow [23], and
Perumalsamy et al. [18], and Park et al. [24], respectively.
Growth inhibitory effect on harmful or nonpathogenic
intestinal bacteria
The inhibitory activities of the seven constituents and
ciprofloxacin against five harmful and two nonpathogenicTable 4 Minimal inhibitory concentrations (MICs) of Asarum h
two nonpathogenic intestinal bacteria using a microtiter plat
Gram-positive bacteriaa
Material Cd Cm Cp
δ-3-Carene 0.70 cB 0.70 eB 0.70 dB
Methyleugenol 0.70 cD 1.47 dC 5.80 bA
1,8-Cineole 1.47 bB 1.47 dB 2.94 cA
Pellitorine 2.94 aA 1.47 dB 0.70 dC
(−)-Asarinin 2.94 aA 2.94 cA 2.94 cA
α-Asarone 2.94 aC 5.80 bB 12.0 aA
Safrole 2.94 aD 23.50 aA 2.94 cD
Ciprofloxacin 0.25 dA 0.125 fB 0.125 eB
Means in a column followed by the same lowercase letter and means in a row follo
Bonferroni test).
aCd, C. difficile ATCC 9689; Cm, C. paraputiricum ATCC 25780; Cp, C. perfringens ATCC
bBf, B. fragilis ATCC 25285; Ec, E. coli ATCC 11775; St, S. enterica serovar Typhimurium
cNonpathogenic bacteria.intestinal bacteria examined were likewise compared
(Table 4). Responses varied according to bacterial species
and compound examined. As judged by MIC values, δ-
3-carene showed the most potent growth inhibitory activ-
ity against four Gram-positive bacteria (0.18–0.70 mg/mL)
and two Gram-negative bacteria (0.18–0.70 mg/mL) ex-
cept for S. enterica serovar Typhimurium (2.94 mg/mL).
The MIC of methyleugenol was 0.70 and 5.80 mg/mL
against C. difficile and C. perfringens, respectively, and was
between 1.47 and 2.94 mg/mL against the other two
Gram-positive bacteria and three Gram-negative bacteria.
The MIC of 1,8-cineole, pellitorine, and (−)-asarinin was
between 1.47 and 2.94 mg/mL against all Gram-positive
bacteria (except for pellitorine against C. perfringens
(0.70 mg/mL)) and three Gram-negative bacteria. The
MIC of α-asarone was between 1.47 and 2.94 mg/mL
against two Gram-positive bacteria except for C.
paraputiricum (5.80 mg/mL) and C. perfringens (12 mg/mL)
and three Gram-negative bacteria. The MIC of safrole
was 2.94 mg/mL against three Gram-positive bacteria
except for C. paraputiricum (23.5 mg/mL) and was
1.47, 7.20, and 12 mg/mL against B. fragilis, E. coli, and
S. enterica serovar Typhimurium, respectively. Overall,
all of the constituents were less potent at inhibiting mi-
crobial growth than ciprofloxacin against all Gram-
positive bacteria (MIC, 0.063–0.25 mg/mL) and three
Gram-negative bacteria (MIC, 0.063–0.125 mg/mL).
Growth inhibitory effect on beneficial intestinal bacteria
The growth inhibitory effects of all compounds on six lactic
acid-producing bacteria (four bifidobacteria and two lacto-
bacilli) and one acidulating bacterium (C. butyricum) were
likewise compared (Table 5). Responses varied according to




Sa Bfc Ecc St
0.18 cC 0.70 cB 0.18 dC 2.94 bA
2.94 aB 2.94 aB 1.47 cC 1.47 cC
1.47 bB 2.94 aA 2.94 bA 2.94 bA
1.47 bB 2.94 aA 1.47 cB 1.47 cB
2.94 aA 2.94 aA 2.94 bA 1.47 cB
1.47 bD 1.47 bD 2.94 bC 1.47 cD
2.94 aD 1.47 bE 7.20 aC 12.0 aB
0.063 dC 0.125 dB 0.063 eC 0.063 dC
wed by the same uppercase letter are not significantly different (P > 0.05;
13124; Sa, S. aureus ATCC 12600.
ATCC 13311.
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hibitory activity against all test bacteria (MIC, 1.47–
5.80 mg/mL). However, the constituent was less potent
at inhibiting microbial growth than ciprofloxacin against
all bacteria (MIC, 0.031–0.063 mg/mL). The MIC of
(−)-asarinin was between 1.47 and 2.94 mg/mL against B.
longum, L. casei, and C. butyricum and was 5.80 mg/mL
against the other four bacteria. Except for C. butyricum
(MIC, 0.7 mg/mL) and B. infantis (5.80 mg/mL), the
MIC of δ-3-carene was 12 mg/mL against the other five
bacteria. The MIC of α-asarone, 1.8-cineole, and
methyleugenol was between 1.47 and 2.94 mg/mL
against B. breve, B. longum, and L. casei (except for α-
asarone and methyleugenol against B. breve (MIC,
5.80 mg/mL)) and was between 12 and 23.50 mg/mL
against the other four bacteria. The toxicity of safrole
was the lowest of any of the constituents.
Effect on morphostructures of test microorganisms
The morphostructural effects of δ-3-carene, α-asarone,
or pellitorine treated with 2 times the MIC of each strain
on two selective Gram-positive bacteria (C. perfringens
ATCC 13124 and S. aureus ATCC 12600) and one
Gram-negative bacteria (E. coli ATCC 11775) were com-
pared with those of ciprofloxacin treated with 2 times
the MIC of each strain. Untreated cells of C. perfringens,
S. aureus, and E. coli were intact and showed a normal
smooth surface (Figure 2 A1, B1, and C1). The scanning
electron micrographs for C. perfringens, S. aureus, and
E. coli treated with δ-3-carene showed inhibition of cell
growth with undivided cells (Figure 2 A2), large surface
collapse along with cell membrane damage (Figure 2 B2),
and abnormality with wrinkled cells (Figure 2 C2), re-
spectively. In the bacterial strains treated with α-
asarone, inhibition of cell growth with undivided cells
in C. perfringens (Figure 2 A3), disruption and lysis of cellTable 5 Minimal inhibitory concentrations (MICs) of Asarum h
Gram-positive intestinal bacteria using a microtiter plate-bas
Compound Bba Bia Bea
δ-3-Carene 12.0 cA 5.80 cB 12.0 aA
Methyleugenol 23.50 aA 23.50 aA 5.80 bC
1,8-Cineole 23.50 aA 12.0 bB 2.94 cC
Pellitorine 2.94 eB 5.80 cA 2.94 cB
(−)-Asarinin 5.80 dA 5.80 cA 5.80 bA
α-Asarone 12.0 cA 12.0 bA 5.80 bB
Safrole 22.70 bB 23.50 aA 12.0 aC
Ciprofloxacin 0.031 fB 0.031 dB 0.031 dB
Means in a column followed by the same lowercase letter and means in a row follo
Bonferroni test).
aLactic acid-producing bacteria: Bb, B. bifidum ATCC 29521; Bi, B. infantis ATCC 2596
4356; Lc, L. casei ATCC 393.
bAcidulating bacterium: Cb, C. butyricum ATCC 25779.membrane in S. aureus (Figure 2 B3), and conversion of
the rod to coccoid form in E. coli (Figure 2 C3) were ob-
served. Most of cells were clustered and stuck to each
other. In the three bacterial strains treated with pellitorine,
cell wall and cytoplasmic membrane were completely
destroyed and intracellular materials were extruded
(Figure 2 A4, B4, and C4). The SEM images for C.
perfringens, S. aureus, and E. coli treated with ciprofloxa-
cin showed destroyed cell wall (Figure 2 A5, B5, and C5).
Unlike pellitorine, conversion of the rod to the coccoid
form was observed in the ciprofloxacin-treated C.
perfringens and E. coli. The coccoid-shaped cells were
clustered and stuck to each other.
Discussion
Among the intestinal microorganisms, clostridia are pos-
sible causative agents of a variety of detrimental condi-
tions involving toxicity, mutagenesis, carcinogenesis, and
accelerating aging by transforming a variety of ingested
or endogenously formed compounds to harmful agents
within the intestinal tract [4,6,7]. On the contrary,
bifidobacteria are often taken as useful indicators of hu-
man health under most environmental conditions, on
the basis that they play important roles in metabolism
such as amino acid and vitamin production, aid defense
against infection, are associated with longevity, antitumor
activities, pathogen inhibition, and immunopotentiation
[2,3,5]. It would, therefore, be desirable to both inhibit the
growth of potential pathogens and/or increase the
numbers of bifidobacteria in the human intestine. For
example, extracts of ginseng (Panax ginseng) root [25]
and green tea (Thea sinensis) leaves [26] have been
shown to not only enhance the growth of bifidobacteria
but also to selectively inhibit various clostridia. In vivo
investigations using human volunteers have shown that
intake of ginseng extract [27] or green tea polyphenolseterotropoides root constituents against seven beneficial
ed antibacterial bioassay
MIC (mg/mL)
Bla Laa Lca Cbb
12.0 aA 12.0 bA 12.0 aA 0.70 eC
1.47 cD 12.0 bB 1.47 cD 23.50 aA
2.94 bC 12.0 bB 2.94 bC 12.0 bB
1.47 cC 2.94 dB 1.47 cC 1.47 dC
1.47 cC 5.80 cA 1.47 cC 2.94 cB
1.47 cC 12.0 bA 1.47 cC 12.0 bA
12.0 aC 22.70 aB 12.0 aC 23.50 aA
0.063 dA 0.063 eA 0.063 dA 0.031 fB
wed by the same uppercase letter are not significantly different (P > 0.05;
2; Be, B. breve ATCC 15700; Bl, B. longum ATCC 15707; La, L. acidophilius ATCC
Figure 2 (See legend on next page.)
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Figure 2 Effect on morphostructural changes in test microorganisms. Scanning electron micrographs of two Gram-positives (A) Clostridium
perfringens ATCC 13124 and (B) Staphylococcus aureus ATCC 12600 and a Gram-negative (C) Escherichia coli ATCC 11775 without or with
treatment of the test compounds. White triangles indicate the morphological changes in cells of the test bacteria treated with corresponding
compounds: A1, untreated, well divided and rod-shaped cells; A2, undivided, growth inhibited cells; A3, undivided, growth inhibited cells; A4,
cell wall and cytoplasmic membrane disruption; A5, growth inhibited cells with cytoplasmic membrane disruption. B1, untreated, smooth and
spherical shaped cells; B2, undeveloped cells with cytoplasmic membrane disruption; B3, cells with damaged cell membrane surface; B4, growth
inhibited cells with membrane disruption; B5, undivided cells with collision. C1, untreated, well divided elongated cells; C2, wrinkled shaped cells;
C3, growth inhibited cells; C4, growth inhibited cells with membrane disruption; C5; growth inhibited cells with collision.
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aspects of feces.
In the current study, the antibacterial principles of
A. heterotropoides root were proved to be the
phenylpropanoids safrole (1), methyleugenol (2) and α-
asarone (4); the monoterpenoids 1,8-cineole (3) and δ-3-
carene (5); the lignan (−)-asarinin (6); the isobutylamide
alkaloid pellitorine (7). These constituents exhibited
growth inhibition of both harmful Gram-positive bacteria
and Gram-negative bacteria examined. Overall, all of the
constituents were less potent at inhibiting microbial growth
than ciprofloxacin. However, the four bifidobacteria, two
lactobacilli, and one acidulating bacterium were less sensi-
tive and more susceptible than the harmful bacteria to the
constituents and to ciprofloxacin, respectively. This original
finding indicates that the A. heterotropoides root-derived
materials may hold promise for the development of
novel and effective antibacterial agents. Similar selective
growth responses were reported in Artemisia princeps var.
orientalis containing the sesquiterpene lactones seco-
tanapartholide A and B [29].
Investigations on the modes of action of naturally oc-
curring antibacterial agents provide practically important
information for the control of bacterial diseases, such as
the most appropriate formulations and delivery means
to be adopted for their future commercialization, and
for the development of selective control alternatives with
novel target sites and low toxicity [30,31]. The modes of
action of plant secondary substances such as alkaloids,
phenolics, and terpenoids have been well reviewed by
Wink [11]. Major targets (activities) include biomembrane
(e.g. membrane disruption or inhibition of membrane pro-
tein), proteins (covalent or noncovalent bonding), specific
interaction (e.g. inhibition of enzymes or ion pumps pro-
tein biosynthesis), and DNA (e.g. inhibition of DNA topo-
isomerase I or inhibition of transcription) [11]. For
example, the monoterpene alcohols citronellol and ge-
raniol appear to cause gross cell wall and cytoplasmic
membrane damage and provoke lysis of Streptococcus
pneumoniae [32], whereas the terpene oxide 1,8-cineole
causes the leakage of 260-nm-light-absorbing material
and renders cells susceptible to sodium chloride [33].
The anti-Staphylococcus aureus activity of the terpene
phenol thymol is due to damage in membrane integrity,which further affects pH homeostasis and equilibrium
of inorganic ions [34]. In addition, the most bioactive
plant secondary substances are known to be more toxic
against Gram-positive bacteria than Gram-negative
bacteria [35-37]. It has been suggested that the toler-
ance of Gram-negative bacteria to antibacterial sub-
stances is related to the hydrophilic surface of their
outer membrane, functioning as a barrier to the pene-
tration of various molecules, and is also associated with
the enzymes in the periplasmic space, which are cap-
able of breaking down the molecules [37,38]. However,
it suggests that Gram-positive bacteria do not have cell
walls [38].
In the current study, SEM observations confirmed
different degrees of physical damage and morphological
alteration to both Gram-positive bacteria and Gram-
negative bacteria treated with δ-3-carene, α-asarone,
pellitorine, or ciprofloxacin. δ-3-Carene and α-asarone
caused growth inhibition or lysis of cells. Pellitorine and
ciprofloxacin caused destruction of the cell wall and
cytoplasmic membrane of the three bacterial strains, al-
though the effects on morphostructures were different.
These disruptions might cause the loss of shape and in-
tegrity of cells which was followed by the cell death.
The current finding indicates that the alkaloid, the
phenylpropanoid, the terpenoid, and the fluoroquino-
lone antibiotic do not share a common mode of action
as described by Wink [11]. In addition, the beneficial
Gram-positive bacteria and the harmful and nonpatho-
genic Gram-negative bacteria were observed to have
different degrees of antimicrobial susceptibility to the
constituents, although the antimicrobial susceptibility
of the harmful Gram-positive bacteria and the harmful
and nonpathogenic Gram-negative bacteria was not ob-
served. Ciprofloxacin susceptibility among the bacterial
groups did not differ greatly. Detailed tests are needed
to fully understand the different susceptibility of the
constituents to bacteria.
Conclusion
A. heterotropoides root-derived preparations containing
the constituents described could be useful as potential
antibacterial products or lead molecules for the preven-
tion or eradication from humans from diseases caused
Perumalsamy et al. BMC Complementary and Alternative Medicine 2013, 13:245 Page 10 of 11
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stituents against harmful intestinal bacteria may be an
indication of at least one of the pharmacological actions
of A. heterotropoides. For practical use of the root-
derived materials as novel antibacterial products to
proceed, further studies are needed to establish their hu-
man safety and whether this activity is exerted in vivo
after consumption of A. heterotropoides root extract and
its constituents by humans. In addition, their antibacter-
ial modes of action need to be established and formula-
tions for improving antibacterial potency and stability
need to be developed.
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